Literature DB >> 22763808

New insights in the prevention, diagnosis, and treatment of cryptococcal meningitis.

Arthur Jackson1, Charles van der Horst.   

Abstract

Cryptococcal meningitis (CM) remains a major cause of morbidity and mortality among immunocompromised patients, especially in areas of high HIV prevalence, although it can also cause disease in the apparently immunocompetent. Improving the management of HIV-associated CM is important to ensure that patients can survive to benefit from increasing access to ART. In this review we focus on recent advances in prevention, diagnosis, and treatment of CM.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22763808     DOI： 10.1007/s11904-012-0127-7

Source DB:  PubMed          Journal:  Curr HIV/AIDS Rep        ISSN： 1548-3568            Impact factor:   5.071


  89 in total

1.  Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial.

Authors:  Annemarie E Brouwer; Adul Rajanuwong; Wirongrong Chierakul; George E Griffin; Robert A Larsen; Nicholas J White; Thomas S Harrison
Journal:  Lancet       Date:  2004-05-29       Impact factor: 79.321

2.  Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells/microL who start HIV therapy in resource-limited settings.

Authors:  David B Meya; Yukari C Manabe; Barbara Castelnuovo; Bethany A Cook; Ali M Elbireer; Andrew Kambugu; Moses R Kamya; Paul R Bohjanen; David R Boulware
Journal:  Clin Infect Dis       Date:  2010-08-15       Impact factor: 9.079

3.  Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy.

Authors:  P G Pappas; J R Perfect; G A Cloud; R A Larsen; G A Pankey; D J Lancaster; H Henderson; C A Kauffman; D W Haas; M Saccente; R J Hamill; M S Holloway; R M Warren; W E Dismukes
Journal:  Clin Infect Dis       Date:  2001-07-26       Impact factor: 9.079

4.  Voriconazole proves effective in long-term treatment of a cerebral cryptococcoma in a chronic nephropathic HIV-negative patient, after fluconazole failure.

Authors:  S Sabbatani; R Manfredi; M Pavoni; A Consales; F Chiodo
Journal:  Mycopathologia       Date:  2004-08       Impact factor: 2.574

5.  A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. National Institute of Allergy and Infectious Diseases Mycoses Study Group.

Authors:  M S Saag; G A Cloud; J R Graybill; J D Sobel; C U Tuazon; P C Johnson; W J Fessel; B L Moskovitz; B Wiesinger; D Cosmatos; L Riser; C Thomas; R Hafner; W E Dismukes
Journal:  Clin Infect Dis       Date:  1999-02       Impact factor: 9.079

6.  Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks.

Authors:  W E Dismukes; G Cloud; H A Gallis; T M Kerkering; G Medoff; P C Craven; L G Kaplowitz; J F Fisher; C R Gregg; C A Bowles; S Shadomy; A M Stamm; R B Diasio; L Kaufman; S Soong; W C Blackwelder
Journal:  N Engl J Med       Date:  1987-08-06       Impact factor: 91.245

7.  A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. California Collaborative Treatment Group.

Authors:  S A Bozzette; R A Larsen; J Chiu; M A Leal; J Jacobsen; P Rothman; P Robinson; G Gilbert; J A McCutchan; J Tilles
Journal:  N Engl J Med       Date:  1991-02-28       Impact factor: 91.245

8.  Evaluation of a newly developed lateral flow immunoassay for the diagnosis of cryptococcosis.

Authors:  Mark D Lindsley; Nanthawan Mekha; Henry C Baggett; Yupha Surinthong; Rinrapas Autthateinchai; Pongpun Sawatwong; Julie R Harris; Benjamin J Park; Tom Chiller; S Arunmozhi Balajee; Natteewan Poonwan
Journal:  Clin Infect Dis       Date:  2011-08       Impact factor: 9.079

9.  Independent association between rate of clearance of infection and clinical outcome of HIV-associated cryptococcal meningitis: analysis of a combined cohort of 262 patients.

Authors:  Tihana Bicanic; Conrad Muzoora; Annemarie E Brouwer; Graeme Meintjes; Nicky Longley; Kabanda Taseera; Kevin Rebe; Angela Loyse; Joseph Jarvis; Linda-Gail Bekker; Robin Wood; Direk Limmathurotsakul; Wirongrong Chierakul; Kasia Stepniewska; Nicholas J White; Shabbar Jaffar; Thomas S Harrison
Journal:  Clin Infect Dis       Date:  2009-09-01       Impact factor: 9.079

10.  Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial.

Authors:  Andrew Zolopa; Janet Andersen; William Powderly; Alejandro Sanchez; Ian Sanne; Carol Suckow; Evelyn Hogg; Lauren Komarow
Journal:  PLoS One       Date:  2009-05-18       Impact factor: 3.240
View more
  8 in total

Review 1.  Update on opportunistic infections in the era of effective antiretroviral therapy.

Authors:  Brian C Zanoni; Rajesh T Gandhi
Journal:  Infect Dis Clin North Am       Date:  2014-09       Impact factor: 5.982

Review 2.  Host immunity to Cryptococcus neoformans.

Authors:  Soma Rohatgi; Liise-Anne Pirofski
Journal:  Future Microbiol       Date:  2015       Impact factor: 3.165

3.  Cryptococcosis in patients living with hepatitis C and B viruses.

Authors:  Fernanda Sá Spies; Markus Berger de Oliveira; Monique Siebra Krug; Cecilia Bittencourt Severo; Luiz Carlos Severo; Marilene Henning Vainstein
Journal:  Mycopathologia       Date:  2014-12-21       Impact factor: 2.574

4.  Point-of-Care Testing for Cryptococcal Disease Among Hospitalized Human Immunodeficiency Virus-Infected Adults in Ethiopia.

Authors:  Admasu Tenna Mamuye; Ethan Bornstein; Obsie Temesgen; Henry M Blumberg; Russell R Kempker
Journal:  Am J Trop Med Hyg       Date:  2016-08-15       Impact factor: 2.345

Review 5.  Tuberculosis Meningitis.

Authors:  Kassem Bourgi; Christina Fiske; Timothy R Sterling
Journal:  Curr Infect Dis Rep       Date:  2017-09-11       Impact factor: 3.725

6.  The impact of routine cryptococcal antigen screening on survival among HIV-infected individuals with advanced immunosuppression in Kenya.

Authors:  A-C L Meyer; C K Kendi; J A Penner; N Odhiambo; B Otieno; E Omondi; E Opiyo; E A Bukusi; C R Cohen
Journal:  Trop Med Int Health       Date:  2013-02-01       Impact factor: 2.622

Review 7.  Cryptococcal meningitis: a review for emergency clinicians.

Authors:  Kathryn Marie Fisher; Tim Montrief; Mark Ramzy; Alex Koyfman; Brit Long
Journal:  Intern Emerg Med       Date:  2021-01-09       Impact factor: 3.397

Review 8.  Cryptococcal meningitis: epidemiology and therapeutic options.

Authors:  Derek J Sloan; Victoria Parris
Journal:  Clin Epidemiol       Date:  2014-05-13       Impact factor: 4.790
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.